News and Publications

Genesis 2017: Rachel Bradley takes part in panel discussion on building trust in digital health

Posted: 15/12/2017

Rachel Bradley, senior associate in Penningtons Manches' life sciences practice, was invited to speak this week at an insightful panel session on building trust in digital health at one of the UK’s foremost life science and healthcare conferences, Genesis 2017.

The presentation covered a number of key issues. Rachel highlighted how cyber security is the first step to building trust, its importance throughout the product lifecycle, and how data security is a crucial area of compliance under the General Data Protection Regulations (GDPR) coming into force in May 2018. She explained the key principles of data protection including consent, privacy by design and data minimisation. She also discussed the new Medical Devices Regulations due to come into effect in 2020 and the In Vitro Diagnostic Devices Regulation which apply from 2022.

The panel was chaired by Peter Ferguson, director of healthcare technologies at ARM. Rachel’s fellow panellists were Andrew Cohen from The Future Care UK and Lloyd Humphreys from Patient Knows Best. The session was led by Collette Johnson of Bespak and sponsored by Cambridge Wireless, a leading industry forum for companies involved in the development and application of wireless technologies.

The Genesis conference is run by One Nucleus, the membership organisation for international life science and healthcare companies of which Penningtons Manches is a long-standing partner.

Arrow GIFReturn to news headlines

Penningtons Manches Cooper LLP

Penningtons Manches Cooper LLP is a limited liability partnership registered in England and Wales with registered number OC311575 and is authorised and regulated by the Solicitors Regulation Authority under number 419867.

Penningtons Manches Cooper LLP